RANDOX LABORATORIES LIMITED
Get an alert when RANDOX LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.7m
-0.7% vs 2024
Net assets
£163m
+35.8% highest in 3 filed years
Employees
1,188
-18.7% lowest in 3 filed years
Profit before tax
-£6.2m
-36.4% lowest in 3 filed years
Net assets
3-year trend · vs Basic Materials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-06-30
| Metric | Trend | 2023-06-30 | 2024-06-30 | 2025-06-30 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £134,183,000 | £136,620,000 | £139,851,000 | +2.4% | |
| Operating profit | £3,005,000 | -£3,989,000 | -£3,881,000 | +2.7% | |
| Profit before tax | £2,803,000 | -£4,540,000 | -£6,191,000 | -36.4% | |
| Net profit | -£5,000 | -£3,143,000 | -£14,016,000 | -345.9% | |
| Cash | £2,377,000 | £2,743,000 | £2,724,000 | -0.7% | |
| Total assets less current liabilities | £130,145,000 | £122,722,000 | £169,038,000 | +37.7% | |
| Net assets | £123,196,000 | £120,053,000 | £163,037,000 | +35.8% | |
| Equity | £123,196,000 | £120,053,000 | £163,037,000 | +35.8% | |
| Average employees | 1,450 | 1,462 | 1,188 | -18.7% | |
| Wages | £54,413,000 | £50,468,000 | £44,775,000 | -11.3% | |
| Directors' remuneration | £180,000 | £180,000 | £551,000 | +206.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|
| Operating margin | 2.2% | -2.9% | -2.8% | |
| Net margin | -0.0% | -2.3% | -10.0% | |
| Return on capital employed | 2.3% | -3.3% | -2.3% | |
| Gearing (liabilities / total assets) | 65.6% | 79.7% | — | |
| Current ratio | 1.01x | 0.94x | 1.16x | |
| Interest cover | 14.88x | -7.24x | -1.68x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors' expectation is that the company and the group will have adequate resources to continue in operational existence for the foreseeable future. In August 2024 the group successfully concluded a refinancing of its banking facilities, significantly increasing available liquidity. At the balance sheet date, the Group had substantial headroom within these facilities. Subsequent to the year end, the group has agreed a further increase in its facilities to support continued investment in manufacturing capacity in response to market opportunities, with legal documentation expected to be finalised by the end of June 2026. Thus, the directors continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- RANDOX LABORATORIES LIMITED · parent
- Randox Laboratories Canada Ltd 100%
- Randox Laboratories Gmbh 100%
- Irlandox Laboratories Q.A. Ltd 100%
- Laboratorios Randox S. L. 100%
- Randox sro 100%
- Randox Laboratories sro 100%
- Randox Australia (Pty) Ltd 100%
- Randox Brasil Ltda 100%
- Randox Laboratories S.A. (Pty) Ltd 100%
- Randox Korea Ltd. 100%
- Randox Laboratories Ltd. (Switzerland) 100%
- Randox Laboratories (I) Pvt. Ltd. 100%
- Randox Laboratories,US Ltd. 100%
- Randox Land Owner Ltd 100%
- Clinical Diagnostics de Puerto Rico 100%
- Randox Laboratories Ltd. (Jamaica) 100%
- Randox Laboratories Sp ZOO 100%
- Randox Laboratories Hong Kong Ltd 100%
- China Laboratories Ltd 100%
Significant events
- “During the year, the Randox group implemented a change to its transfer pricing policy in respect of the pricing of goods supplied by Randox Laboratories Limited to certain overseas Randox group subsidiaries.”
- “In August 2024 the group successfully concluded a refinancing of its banking facilities, significantly increasing available liquidity.”
- “Subsequent to the year end, the group has agreed a further increase in its facilities to support continued investment in manufacturing capacity in response to market opportunities, with legal documentation expected to be finalised by the end of June 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FITZGERALD, Stephen P | Secretary | 1982-04-20 | — | — |
| DORAN, Adrian | Director | 2024-07-11 | Aug 1969 | Northern Irish |
| FITZGERALD, Nuala | Director | 2022-12-01 | Nov 1958 | British |
| FITZGERALD, Stephen Peter, Dr | Director | 1982-04-20 | Aug 1950 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FITZGERALD, Clement D | Director | 1982-04-20 | 2006-12-21 |
| FITZGERALD, R J | Director | 1982-04-20 | 2010-08-02 |
| FITZGERALD, Robert J | Director | 1982-04-20 | 2010-08-02 |
| KELLY, Richard Patrick | Director | 2006-12-21 | 2022-08-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Randox Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2017-02-01 | Active |
Filing timeline
Last 20 of 197 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-08-12 MA Memorandum articles
- 2024-08-12 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-06 | AA | accounts | Accounts with accounts type full | |
| 2026-07-01 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-30 | SH01 | capital | Capital allotment shares | |
| 2025-06-27 | AA | accounts | Accounts with accounts type full | |
| 2025-02-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-19 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-19 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-19 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-16 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-16 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-12 | MA | incorporation | Memorandum articles | |
| 2024-08-12 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-30 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-07-30 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2024-07-24 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-08 | AA | accounts | Accounts with accounts type full | |
| 2024-02-26 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.